Cardiol Therapeutics
$3.93
2.34%
(+0.09)
Previous close $3.84
$4.85
1.68%
(+0.08)
Previous close $4.77
Latest Updates on CRDL
CRDL
-
Alert: NICI Membership Portfolio Review: All the Biggest Stock Price Movements You Need to Know in September 2021
-
Alert: Inner Circle Portfolio Review: Pot Stock Performances in September
-
Alert: After an Exciting Nasdaq Listing Sent Shares Soaring, CEO David Elsley Gives a Glimpse Into Cardiol’s Future (New Founder’s Roundtable)
-
Alert: NICI Membership Portfolio Review: All the Biggest Stock Price Movements You Need to Know in September 2021
-
Alert: Inner Circle Portfolio Review: Pot Stock Performances in September
-
Alert: After an Exciting Nasdaq Listing Sent Shares Soaring, CEO David Elsley Gives a Glimpse Into Cardiol’s Future (New Founder’s Roundtable)
Loading Chart...
Loading Chart...
Latest Trading on NASDAQ
$3.93
2.34%
(+0.09)
| Open | 3.95 |
|---|---|
| Previous Close | 3.84 |
| Today's Range |
3.56
4.00
|
| 52 Week Range |
1.82
4.90
|
| Volume | 905.96K |
| Avg. Volume (Weekly) | 694.74K |
| Bid | 3.84 |
|---|---|
| Ask | 3.93 |
| Market Cap | 166.40K |
| EPS | -0.13 |
| Shares Outstanding | 43.33K |
| YTD High | 4.90 |
Latest Trading on TSX
$4.85
1.68%
(+0.08)
| Open | 4.84 |
|---|---|
| Previous Close | 4.77 |
| Today's Range |
4.41
4.94
|
| 52 Week Range |
2.32
6.19
|
| Volume | 287.56K |
| Avg. Volume (Weekly) | 241.70K |
| Bid | 4.75 |
|---|---|
| Ask | 4.85 |
| Market Cap | 204.86K |
| EPS | -0.86 |
| Shares Outstanding | 42.95K |
| YTD High | 6.19 |
No data to display.
No data to display.
Cardiol Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease. The company’s lead product consist CardiolRx(TM). Cardiol Therapeutics Inc. is based in Oakville, ON.